Skip to main content

Table 1 Demographic- and disease-related data at inclusion for the total sample and with respect to presence or absence of depressive symptoms and with regard to disease severity

From: Use of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study

 

Total

EDSS mild

EDSS moderate

EDSS severe

Depressive symptoms

No depressive symptoms

Depressive symptoms

No depressive symptoms

Depressive symptoms

No depressive symptoms

n = 173

n = 39a

n = 72

n = 16b

n = 14

n = 16c

n = 16

Women, n (%)

116 (67)

28 (72)

51 (71)

9 (56)

7 (47)

10 (62)

11 (69)

Mean age, years (sd)

46 (12)

42 (13)

43 (11)

47 (9)

55 (10)

56 (11)

53 (12)

Cohabiting, n (%)

123 (71)

31 (79)

51 (71)

11 (69)

9 (64)

11 (69)

11 (69)

Working full- or part-time, n (%)d

114 (66)

24 (65)

59 (84)

7 (47)

7 (64)

0

7 (46)

Immunomodulatory treatment, n (%)

146 (84)

30 (77)

57 (79)

15 (94)

14 (100)

14 (88)

16 (100)

Mean years since diagnosis, (sd)

13 (10)

9 (7)

12 (10)

15 (10)

15 (10)

19 (9)

20 (11)

Disease severity, n (%)

       

   EDSS mild 1.0-3.5

111 (64)

1.8 (1.0-3.5)

1.8 (1.0-3.5)

    

   EDSS moderate 4.0-5.5

30 (17)

  

4.7 (4.0-5.5)

4.6 (4.0-5.5)

  

   EDSS severe 6.0-9.5

32 (18)

    

7.3 (6.0-8.0)

7.0 (6.0-8.0)

Disease course, n (%)

       

   Relapsing remitting

106 (61)

35 (90)

62 (86)

3 (19)

4 (29)

0

2 (13)

   Secondary progressive

58 (34)

1 (2)

7 (10)

12 (75)

9 (64)

16 (100)

13 (81)

   Primary progressive

9 (5)

3 (8)

3 (4)

1 (6)

1 (7)

0

1 (6)

  1. a11 (28%) people with MS used antidepressant drugs.
  2. b6 (38) people with MS used antidepressant drugs.
  3. c5 (31%) people with MS used antidepressant drugs.
  4. dbased on PwMS < 65 years, n = 159.